Latest Automation News

Caspin Resources has delivered exceptional high-grade tin results from its maiden drilling at the Bygoo North Prospect, confirming a large-scale mineralised system with significant growth potential. Concurrently, metallurgical test work advances at Mount Squires for rare earth extraction.

Strategic Elements Ltd (ASX: SOR) reported meaningful progress in its Energy Ink™ technology and underground mining platform during Q1 2025, while maintaining a robust cash balance and preparing for international collaborations.

IMEXHS Limited reported modest revenue growth and a 16% increase in ARR in Q1 FY25, alongside the commercial rollout of its Aquila+ radiology platform and a $2.5 million capital raising to fuel expansion.

Norwood Systems has landed a significant five-year contract with Optus to overhaul its voicemail platform, delivering early milestones on schedule and strengthening its financial position. The company is also advancing its global pipeline with Tier-1 telecom operators and deepening strategic partnerships with Microsoft Azure and AWS.

Cape Range Ltd’s Malaysian software arm Biztrak delivered robust 29% revenue growth in Q1 2025, driven by e-invoicing initiatives, even as a planned rights issue was cancelled due to shareholder withdrawal amid market volatility.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Linius Technologies embarks on a strategic transformation under CEO Ben Taverner, focusing on operational restructuring, AI-enhanced SaaS products, and market expansion beyond sports to achieve breakeven by June 2026.

Locate Technologies Limited reported flat group revenue for Q3 FY25, with Locate2u growing 10% while Zoom2u declined 11%. The company continues to embed AI as a strategic growth and cost optimization tool.

Pointerra Limited’s Q3 FY25 results reveal delayed invoicing milestones pushed into Q4, yet strong progress across multiple sectors and promising product development underpin an optimistic cashflow outlook.

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Mad Paws Holding Limited reported a robust 22% year-on-year growth in Gross Merchandise Value over March-April 2025, driven by marketplace momentum despite a 6% decline in group operating revenue. Strategic marketing campaigns and operational enhancements underpin the company’s growth trajectory.

Mad Paws Holdings Limited reported a resilient Q3 FY25 with an 8% rise in Group Cash EBITDA despite a 6% dip in operating revenue, driven by marketplace strength and a major new brand campaign.